A 58-year-old Chinese female, gravidity 4 parity 3 (G4P3), presented with a cough and chest pain in March 2021. Diagnostic workup revealed lung cancer with multiple metastases to the cervical lymph nodes, brain, and bone. On 15 March 2021, she was administered chemotherapy intravenously with pemetrexed and carboplatin, along with bevacizummab. Subsequently, on 11 April 2021, based on genetic testing results, her treatment regimen was adjusted to dacomitinib (oral, once daily). The patient has been adherent to this targeted therapy regimen since then. On 29 April 2022, she was admitted to the hospital due to lumbosacral pain and discomfort, accompanied by slight numbness in the left lower limb. The patient had a history of hypertension but no other significant personal or family history. She, a farmer, has no history of smoking, drinking, or morphine use.
